< Back

A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II study to assess the efficacy and safety of daily OM-85 treatment versus placebo given on top of standard of care in children aged 6 months to 5 years with recurrent wheezing episode Open


A clinical study investigating OM-85 efficacy and safety in children suffering from recurrent wheezing

Study Details
Internal Title: EAGLE

PCH IRB Number: S-IRB-23-017
Clinical Trials Government Identifier: NCT05857930

Diagnoses & Treatments: Recurrent wheezing, Broncho-Vaxom, cough, asthma

Study Type: Clinical Trial

Eligibility: Ages 6m-5 years with recurrent wheezing

Enrollment Status: Open

Phase: II


Coordinator Contact: MELVIN VARGHESE
Contact Email:


Principal Investigator
Principal Investigator Photo
Division Chief and Medical Director, Allergy and Immunology; Co-Director, Multidisciplinary Eosinophilic Gastrointestinal Disease Clinic